Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IB-II Clinical Trial of Melatonin Oral Gel for the Prevention and Treatment of Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation.

NCT02630004 is registered in ClinicalTrials.gov with Spherium Biomed as lead sponsor.

NCT NCT02630004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02630004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IB-II Clinical Trial of Melatonin Oral Gel for the Prevention and Treatment of Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation.
Lead sponsor
Spherium Biomed
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2015
Completion date
December 22, 2017
Enrollment
84 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis